A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC

Clinical trial NCT03295006 · COMPLETED

Trial details

NCT number: NCT03295006
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2016-10-31
Primary completion: 2020-12-01
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.